Provided by Vindico Medical Education
Release Date: March 15, 2016
Expiration Date: March 15, 2017
Physician Continuing Medical Education
Vindico Medical Education is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
Vindico Medical Education designates this enduring material for a maximum of 1.0 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Type of Activity
Knowledge and Performance
The intended audience for this activity is gastroenterologists, hepatologists, nurse practitioners, physician assistants, and other health care professionals involved in the treatment of patients with HCV.
This activity is supported by an educational grant from Gilead Sciences Medical Affairs.
Disclosure of Conflicts of Interest
In accordance with the Accreditation Council for Continuing Medical Education’s Standards for Commercial Support, all CME providers are required to disclose to the activity audience the relevant financial relationships
of the planners, teachers, and authors involved in the development of CME content. An individual has a relevant financial relationship if he or she has a financial relationship in any amount occurring in the last 12 months with a commercial interest whose products or services are discussed in the CME activity content over which the individual has control. Faculty
The faculty reported the following financial relationships or relationships they or their spouse/life partner have with commercial interests related to the content of this continuing education activity:
Andrew J. Muir, MD, MHS has received Consulting Fees: AbbVie, Achillion, Bristol-Myers Squibb, Gilead, Janssen, Merck, Theravance.
Contracted Research: AbbVie, Achillion, Bristol-Myers Squibb, Gilead, Janssen, Merck, Roche, Theravance.
Nancy Reau, MD, FAASLD, AGAF has received Consulting Fees: AbbVie, Bristol-Myers Squibb, Gilead, Janssen, Salix.
Contracted Research: AbbVie, Boehringer-Ingelheim, Bristol-Myers Squibb, Gilead, Merck.
Mark Sulkowski, MD has received Consulting Fees: AbbVie, Achillion, Gilead, Janssen, Merck.
Contracted Research (paid directly to institution): AbbVie, Bristol-Myers Squibb, Gilead, Janssen, Merck. External Reviewers Joseph K. Lim, MD
has received Consulting Fees
: Boehringer-Ingelheim, Bristol-Myers Squibb, Gilead, Merck. Contracted Research
: Abbott, Bristol-Myers Squibb, Gilead, Hologic, Janssen. Ronald A. Codario, MD, FACP, FNLA, CCMEP
has no relevant financial relationship to disclose.
Vindico Medical Education Staff: No relevant financial relationships to disclose.
Signed disclosures are on file at Vindico Medical Education, Office of Medical Affairs and Compliance.
Disclosure of Unlabeled Use
The audience is advised that this continuing medical education activity may contain references to unlabeled uses of US Food and Drug Administration (FDA)-approved products or to products not approved by the FDA for use in the United States. The faculty members have been made aware of their obligation to disclose such usage. All activity participants will be informed if any speakers/authors intend to discuss either non-FDA approved or investigational use of products/devices.
Media Method of Participation and Request for Credit
The material presented at or in any Vindico Medical Education continuing education activity does not necessarily reflect the views and opinions of Vindico Medical Education. Neither Vindico Medical Education, nor the faculty endorse or recommend any techniques, commercial products, or manufacturers. The faculty/authors may discuss the use of materials and/or products that have not yet been approved by the U.S. Food and Drug Administration. All readers and continuing education participants should verify all information before treating patients or utilizing any product.
To participate in this CME activity, you must complete the activity in its entirety and complete the CME posttest and evaluation. Provide only one (1) correct answer for each question. A satisfactory score is defined as answering 80% of the questions correctly. Upon receipt of the completed materials, if a satisfactory score on the posttest is achieved, Vindico Medical Education will issue an AMA PRA Category 1 Credit(s)™